Our Story

Where Ancient WisdomMeets Modern Validation

EleganC Bio is the realization of a 16-year friendship between co-founders Zaka and Khizr — a partnership built on trust, shared heritage, and a common vision to transform the nutraceutical industry.

Our partnership began long before the lab, built on a foundation of shared trust and a common South Asian heritage where natural remedies have been a cornerstone of health for generations. It was during Zaka's PhD research at the University of Georgia's Complex Carbohydrate Research Center (CCRC) that we identified a critical gap: the world's most powerful traditional botanicals often lacked the data required for modern validation.

We realized that by combining high-resolution structural chemistry with biological proof, we could turn ancient botanical wisdom into a rigorous, data-driven standard.

By integrating NMR structural elucidation with C. elegans phenotypic screening, we are developing a pipeline of proprietary, licensable IP for the global nutraceutical industry. At EleganC Bio, we are moving beyond simple discovery to provide the molecular and mechanistic certainty that the next generation of healthcare innovators requires to scale with confidence.

Our Journey

2008

A Friendship Begins

Zaka and Khizr meet, beginning a 16-year partnership rooted in shared South Asian heritage and a deep respect for traditional natural remedies.

2018

PhD Research at UGA CCRC

Zaka begins doctoral research at the University of Georgia's Complex Carbohydrate Research Center, mastering NMR structural elucidation and C. elegans biological screening.

2022

Identifying the Gap

During Zaka's research, a critical insight emerges: the world's most powerful traditional botanicals lack the rigorous data required for modern IP validation.

2025

EleganC Bio is Founded

Combining high-resolution structural chemistry with biological proof, Zaka and Khizr launch EleganC Bio to turn ancient botanical wisdom into a data-driven standard.

Meet the Founders

Zaka, Co-Founder & Chief Scientist

Zaka

Co-Founder & Chief Scientist

Zaka holds a PhD from the University of Georgia's Complex Carbohydrate Research Center (CCRC), where he developed expertise in high-resolution NMR structural elucidation and C. elegans phenotypic screening. His research bridges the gap between traditional botanical knowledge and modern molecular validation, enabling the creation of patent-ready scientific dossiers. With access to 900 MHz Bruker NMR spectrometers and institutional-grade facilities, Zaka ensures every data point produced by EleganC Bio meets the highest standards of scientific rigor.

Khizr, Co-Founder & Strategy Lead

Khizr

Co-Founder & Strategy Lead

Khizr is a finance professional and strategist who brings rigorous financial discipline to EleganC Bio's commercial ambitions. Trained in accounting and finance at IBA Karachi and holding an MS in Technology Management & Entrepreneurship from LUMS, he combines deep technical financial expertise with a sharp entrepreneurial instinct.

His career spans assurance and audit at A.F. Ferguson & Co. (PwC network) and a Finance Manager role at Enabling Qapital AG — a Swiss impact investment firm — where he built financial models, led ERP implementations, and established the reporting infrastructure that underpins institutional-grade operations. He is a certified Financial Modelling & Valuation Analyst (FMVA), with hands-on expertise in IFRS and Swiss GAAP reporting, strategic budgeting, and KPI frameworks.

At EleganC Bio, Khizr channels this foundation into building a venture that is as commercially sound as it is scientifically rigorous. He translates the company's breakthrough research into market-ready product offerings, structures licensing frameworks, manages strategic partnerships, and ensures the business is positioned with the financial credibility that serious brands and investors demand — building the engine that takes it to market.

Let's Build the Future Together

Partner with us to transform your botanical formulations into validated, licensable intellectual property.

Book a Discovery Call